T-cell recognition of acetylcholine receptor provides a reliable means for monitoring autoimmunity to acetylcholine receptor in antibody-negative myasthenia gravis patients

References

• Lindstrom JM, Seybold ME, Lennon VA, Whittingham S, Duane DD. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology. 1976; 26:1054–1059.
   PubMed Web of Science ®Google Scholar
• Vincent A. Unravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol. 2002; 2:797–804.
   PubMed Web of Science ®Google Scholar
• Vincent A, Newsom-Davis J. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: Results in 153 validated cases and 2967 diagnostic assays. J Neurol Nuerosurg Psychiatry. 1985; 48:1246–1252.
   PubMed Web of Science ®Google Scholar
• Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med. 2001; 7:365–368.
   PubMed Web of Science ®Google Scholar
• Oh SJ. Muscle-specific receptor tyrosine kinase antibody positive myasthenia gravis current status. J Clin Neurol. 2009; 5:53–64.
   PubMed Web of Science ®Google Scholar
• Muppidi S, Wolfe GI. Muscle-specific receptor tyrosine kinase antibody positive and seronegative myasthenia gravis. Front Neurol Neurosci. 2009; 26:109–119.
   PubMedGoogle Scholar
• Leite MI, Jacob S, Viegas S, Cossins J, Clover L, Morgan BP, Beeson D, Willcox N, Vincent A. IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis. Brain. 2008; 131:1940–1952.
   PubMed Web of Science ®Google Scholar
• Hohlfeld R, Toyka KV, Tzartoss SJ, Carson W, Conti-Tronconi B. Human T-helper lymphocytes in myasthenia gravis recognize the nicotinic receptor α subunit. Proc Natl Acad Sci USA. 1987; 84:5379–5383.
   PubMed Web of Science ®Google Scholar
• Oshima M, Ashizawa T, Pollack MS, Atassi MZ. Autoimmune T cell recognition of human acetylcholine receptor: The sites of T cell recognition in myasthenia gravis on the extracellular part of the α subunit. Eur J Immunol. 1990; 20:2563–2569.
   PubMed Web of Science ®Google Scholar
• Oshima M, Deitiker PR, Mosier DR, Smith RG, Atassi MZ. Responses in vitro of peripheral blood lymphocytes from patients with myasthenia gravis to stimulation with human AChR α-chain peptides: Analysis in relation to age, thymic abnormality and ethnicity. Hum Immunol. 2005; 66:32–42.
   PubMed Web of Science ®Google Scholar
• Karni A, Zisman E, Katz-Levy Y, Paas-Rozner M, Dayan M, Brautbar C, Abramsky O, Sela M, Mozes E. Reactivity of T cells from seronegative patients with myasthenia gravis to T cell epitopes of the human acetylcholine receptor. Neurology. 1997; 48:1638–1642.
   PubMed Web of Science ®Google Scholar
• Deitiker PR, Oshima M, Smith RG, Mosier DR, Atassi MZ. Subtle differences in HLA DQ haplotype-associated presentation of AChR α-chain peptides may suffice to mediate myasthenia gravis. Autoimmunity. 2006; 39:277–288.
   PubMed Web of Science ®Google Scholar
• Mulac-Jericevic B, Manshouri T, Yokoi T, Atassi MZ. The regions of α-neurotoxin binding on the extracellular part of the α-subunit of human acetylcholine receptor. J Protein Chem. 1988; 7:173–177.
   PubMedGoogle Scholar
• Jaretzki A 3rd, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, Sanders DB, Myasthenia gravis: recommendations for clinical research standards. Task force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America.
   Google Scholar
• Pera C, Delfino L, Longo A, Pistillo MP, Ferrara GB. Novel associations among HLA-DQA1 and -DQB1 alleles, revealed by high-resolution sequence-based typing (SBT). Tissue Antigens. 2000; 55:275–279.
   PubMedGoogle Scholar
• Olerup O, Aldener A, Fogdell A. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens. 1993; 41:119–134.
   PubMed Web of Science ®Google Scholar
• Klitz W, Maiers M, Spellman S, Baxter-Lowe LA, Schmeckpeper B, Williams TM, Fernandez-Vina M, New HLA. haplotype frequency reference standards: High-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans. Tissue Antigens. 2003; 62:296–307.
   PubMedGoogle Scholar
• Maiers M, Gragert L, Klitz W. High-resolution HLA alleles and haplotypes in the United States population. Human Immunol. 2007; 68:779–788.
   PubMed Web of Science ®Google Scholar
• Deitiker PR, Oshima M, Smith RG, Mosier D, Atassi MZ. Association with HLA DQ of early onset myasthenia gravis in Southeast Texas region of the United States. Int J Immunogenet. 2011; 38:55–62 [Epub 25 November 2010; doi:10.1111/j.1744-313X.2010.00979.x].
   PubMed Web of Science ®Google Scholar
• Deitiker PR, Oshima M, Jankovic J, Duane DD, Aoki KR, Atassi MZ. Association of HLA Class II alleles and haplotypes with cervical dystonia: HLA DR13-DQ6 (DQB1*0604) homozygotes are at greatly increased risk of cervical dystonia in Caucasian Americans. Autoimmunity. 2010; 44:167–176 [Epub ahead of print 2010 Sep 15; doi:10.3109/08916934.2010.509121].
   PubMed Web of Science ®Google Scholar
• Zar JH. 1996. Biostatistical analysis. Englewood Cliffs, New Jersey: Prentice Hall.
   Google Scholar
• Hohlfeld R, Kalies I, Kohleisen B, Heininger K, Conti-Tronconi B, Toyka KV. Myasthenia gravis: Stimulation of antireceptor autoantibodies by autoreactive T cell lines. Neurology. 1986; 36:618–621.
   PubMed Web of Science ®Google Scholar
• Ofosu-Appiah W, Mokhtarian F, Shirazian D, Grob D. Production of anti-acetylcholine receptor-α antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: Role of immunoregulatory T cells and monocytes. J Lab Clin Med. 1994; 124:231–241.
   PubMed Web of Science ®Google Scholar
• Rosenberg JS, Oshima M, Atassi MZ. B-cell activation in vitro by helper T cells specific to region α146–162 of Torpedo californica nicotinic acetylcholine receptor. J Immunol. 1996; 157:3192–3199.
   PubMed Web of Science ®Google Scholar
• Wang ZY, Okita DK, Howard JF, Conti-Fine BM. Th1 cells of myasthenia gravis patients recognize multiple epitopes on the muscle acetylcholine receptor α subunit. Ann NY Acad Sci. 1998; 841:329–333.
   PubMed Web of Science ®Google Scholar
• Willcox N, Schluep M, Ritter MA, Newsom-Davis J. The thymus in seronegative myasthenia gravis patients. J Neurol. 1991; 238:256–261.
   PubMed Web of Science ®Google Scholar
• Atassi MZ, Casali P. Molecular mechanisms of autoimmunity. Autoimmunity. 2008; 41:123–132.
   PubMed Web of Science ®Google Scholar
• Baggi F, Antozzi C, Andreetta F, Confaloniri P, Ciusani E, Begovich AB, Erlich HA, Cornelio A, Mantegazza R. Identification of a novel HLA class II association with DQB1*0502 in an Italian myasthenic population. Ann NY Acad Sci. 1998; 841:355–359.
   PubMed Web of Science ®Google Scholar
• Yousefipour GA, Salami Z, Farjadian S. Association of HLA-DQA1*0101/2 and DQB1*0502 with myasthenia gravis in southern Iranian patients. Iran J Immunol. 2009; 6:99–102.
   PubMed Web of Science ®Google Scholar
• Saruhan-Direskeneli G, Kilic A, Parman Y, Serdaroglu P, Deymeer F. HLA-DQ polymorphism in Turkish patients with myasthenia gravis. Hum Immunol. 2006; 67:352–358.
   PubMed Web of Science ®Google Scholar
• Hayashi A, Shiono H, Ohta M, Ohta K, Okumura M, Sawa Y. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis. J Neuroimmunol. 2007; 189:163–168.
   PubMed Web of Science ®Google Scholar